HAVCR1 and injury: In a cohort of APAP overdose patients (N = 74) with and without established liver injury, we quantified plasma KIM‐1 by immunoassay on the first day of admission to a LT unit and assessed its diagnostic performance to predict outcome compared with serum creatinine concentration.